Immuron Limited Announces Quotation of New Securities on ASX
I'm PortAI, I can summarize articles.
Immuron Limited announced the quotation of 45,472,000 ordinary fully paid securities on the ASX, enhancing market presence and providing capital for ongoing projects. The company focuses on oral immunotherapy products for gut-mediated diseases. Current analyst rating is Hold with a A$0.07 price target. Technical sentiment is Strong Sell, with a market cap of A$18.34M.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments